6-K - SLMT - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number 001-41606

BRERA HOLDINGS PLC

(Translation of registrant’s name into English)

Connaught House, 5th Floor

One Burlington Road

Dublin 4

D04 C5Y6

Ireland

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

On October 22, 2025, Brera Holdings PLC (the “Company”) (NASDAQ: SLMT), a Solana-based crypto infrastructure company, entered into a Waiver and Consent (the “Waiver and Consent”) with certain holders of the Company’s securities (who collectively beneficially own at least 50.1% of the then outstanding Registrable Securities, as defined in the Registration Rights Agreement dated September 18, 2025 (the “Registration Rights Agreement”)). The Waiver and Consent waives the compliance of the Filing Date (as defined in the Registration Rights Agreement) and extends the deadline for the Company to file the initial resale registration statement with the Securities and Exchange Commission to the 60th calendar day following the Closing Date (as defined in the Registration Rights Agreement).

The foregoing descriptions of the Waiver and Consent and Registration Rights Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Waiver and Consent and Registration Rights Agreement, which are attached hereto as Exhibits 10.1 and 10.2, respectively, to this Report on Form 6-K and are incorporated herein by reference.

EXHIBIT INDEX

Exhibit No.	Description
10.1	Form of Waiver and Consent, dated October 22, 2025
10.2	Form of Registration Rights Agreement, dated as of September 18, 2025, between Brera Holdings PLC and each Holder (as defined therein) (Incorporated by reference to Exhibit 10.2 filed on Form 6-K September 18, 2025)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BRERA HOLDINGS PLC
Date: October 22, 2025	By:	/s/ Marco Santori
		Name:	Marco Santori
		Title:	Chief Executive Officer

Exhibit 10.1

WAIVER AND CONSENT

This waiver and consent (this “Waiver and Consent”) dated October 22, 2025, by and between Brera Holdings PLC, a public limited company incorporated in Ireland (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”), is being delivered pursuant to Section 6(d) of the Registration Rights Agreement by and between the Company and the Purchasers, dated September 18, 2025 (the “Agreement”). Capitalized terms used herein, unless otherwise defined, shall have the meanings set forth in the Agreement.

RECITALS

WHEREAS, pursuant to Section 2(a) of the Agreement, the Company is required to prepare and file or cause to be prepared and filed with the Commission, a Registration Statement no later than October 23, 2025.

WHEREAS, the Company is seeking (i) waiver of compliance with the Filing Date and (ii) to amend the Filing Date to 60 days following the Closing Date, in each case in accordance with Section 6(d) of the Agreement, which provides that any of the provisions, covenants and conditions set forth in the Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified, with the written consent of (i) the Company and (ii) the Holders of at least 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes any Registrable Securities issuable upon exercise or conversion of any security); and

NOW THEREFORE, in consideration of the mutual covenants contained in this Waiver and Consent, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

1.	Waiver and Amendment. Each Purchaser hereby (i) waives compliance with the Filing Date requirement<br>under Section 2(a) of the Agreement and (ii) consents to amending the Filing Date to be 60 days from the Closing Date.
2.	Limited Effect of Waiver. The execution, delivery and effectiveness of this Waiver and Consent<br>shall not, except as expressly provided herein, (A) waive or modify any right, power or remedy under, or any other provision of the Agreement<br>or (B) commit or otherwise obligate the Purchasers to enter into or consider entering into any other waiver or modification of the Agreement.
---	---
3.	Miscellaneous. All communications and notices hereunder shall be given as provided in the Agreement.<br>This Waiver and Consent (a) shall be governed by and construed in accordance with the law of the State of New York, (b) is for the exclusive<br>benefit of the parties hereto and, together with the Agreement, constitutes the entire agreement of such parties, superseding all prior<br>agreements among them, with respect to the subject matter hereof, (c) may be modified, waived or assigned only in writing by both the<br>Company and the Purchasers, and only to the extent such modification, waiver or assignment would be permitted under the Agreement (and<br>any attempt to assign this Waiver and Consent without such writing shall be null and void), and (d) is a negotiated document, entered<br>into freely among the parties upon advice of their own counsel, and it should not be construed against any of its drafters. If any term<br>or provision of this Waiver and Consent is held invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or<br>unenforceability shall not affect any other term or provision of this Waiver and Consent or invalidate or render unenforceable such term<br>or provision in any other jurisdiction. Upon such determination that any term or provision is invalid, illegal or unenforceable, the parties<br>shall negotiate in good faith to modify this Waiver and Consent to effect the original intent of the parties as closely as possible.
---	---

[Signature pages follows]

IN WITNESS WHEREOF, the undersigned have executed this Waiver and Consent as of the date first above written.

BRERA HOLDINGS PLC
By:
	Name:	Marco Santori
	Title:	Chief Executive Officer

[SIGNATURE PAGES OF PURCHASERS FOLLOWS]

[SIGNATURE PAGE OF PURCHASERS]

Name of Holder: __________________________

Signature of Authorized Signatory of Holder: __________________________

Name of Authorized Signatory: _________________________

Title of Authorized Signatory: __________________________